Professional Documents
Culture Documents
Hypersensitivity Reactions (Types I, II, Iii, Iv) : April 15, 2009
Hypersensitivity Reactions (Types I, II, Iii, Iv) : April 15, 2009
Allergen
W
W
A
ET
Immune
CS
ADCC
Antigen Immune complex
C3b.097 Allergen Fc receptor
Sensitized TH1 for IgE
Fc receptor Cyto Complement
C3b V Allergen
toxic activation specific
Surface cell
tokines IgE
Target antigen cell
Complement
activation
Neutrophil Immune
2 complex Degranulation
Activated macrophage Type I
Type II
Type III
Type IV IgE-Mediated Hypersensitivity IgG-or IgM-Mediated
Cytotoxic Immune Complex-Mediated Cell-Mediated
Hypersensitivity
Hypersensitivity
Hypersensitivity Ag
induces cross-linking of Ab directed against
cell surface Ag-Ab complexes deposited Sensitized Th1 cells
shown above IgE bound to mast cells and antigens meditates cell in various
tissues induce release cytokines that activate basophils with release of
destruction via complement complement activation and macrophages or T
cells that vasoactive mediators. activation or ADCC.
an ensuing inflammatory mediate direct cellular damage. response mediated by
massive TH2 cells and CTLs mediate
infiltration of neutrophils. similar responses. Typical
manifestations include Typical manifestations include Typical
manifestations include Typical manifestations include systemic
anaphylaxis and blood transfusion reactions, localized Arthus reaction and
contact dermatitis, tubercular localized anaphylaxis such as erythroblastosis
fetalis, and generalized reactions such lesions, and graft rejection.
hay fever, asthma, hives, food autoimmune hemolytic as serum
sickness, necrotizing allergies, and eczema.
anemia.
vasculitis, glomerulonephritis, rheumatoid arthritis, and systemic
lupus erythematosus.
Figure 15-1 Kuby IMMUNOLOGY, Sixth Edition © 2007 W. H. Freeman and Company
- Type I
Produce effector molecules
Capable of ingesting foreign Particles
Association with parasite infection
Modified from Abbas, Lichtman & Pillai, Table 19-1
Type I hypersensitivity
response
VH VL
Cε1 CL
Binds to mast cell
Normal serum level = 0.0003 mg/ml
IgE
Link
Binds Fc region of IgE
Intracellular signal trans.
Initiation of degranulation
Allergen
IgE
Degranulation
FCERI
12_FCERI
Fusogens
600000014
0000000
0000000
Joel00000
Vocca0000
0000000
0000000
0000000
0000000
00000000
00000000
0000000
0000000
PC Lyso PG SPMT11) SY EPMT I PELS Tipase Az
Phospho
ise
DAGATE PIP2
Phospho
Nipase CAT (PKC (PKC PTO
ATP inactive active
CAMP (transient) 1
Protein kinase
→ Protein inactive
active
MAPK
Microtubules and micro filaments, SNARE complex
Swollen granule
kinase
→ (PKC
Mediators (e.g., histamine) ) Granule
→ Ca2+
Cytokines
Arachidonic acid
TNE Leukotriene Ace Prostaglandin D, GM-CSF
(PGD2) IL-3
LTB4 IL-4
LTC4 IL-5
LTD4 SRS-A IL-13 LTE4
inflam-
Wn-cell barwngratu
TMHC Chelmolaule
Atopic dermatith
•T 1-cell-mediated
induction of Latinocyte
•T 1 cell-mediated epithellal
of chemokind pro-inflammatory cytoline
TABLE 15-3
Principal mediators involved in type I hypersensitivity
Effects
Mediator
PRIMARY
SECONDARY
SHRIJE
status
• Genetic risk factors
• “Hygiene hypothesis”
– Older siblings, day care – Exposure
to certain foods, farm animals –
Exposure to antibiotics during infancy
• Cytokine milieu
Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy
Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin
Immunol 7:91-95, 2007
TABLE 15-1
Common allergens associated with type 1
hypersensitivity
Proteins
Foreign serum Vaccines
Foods
Nuts Seafood Eggs Peas, beans Milk
Plant pollens
Rye grass Ragweed Timothy grass Birch trees
Insect products
Bee venom Wasp venom Ant venom Cockroach calyx
Dust mites
Drugs
Penicillin Sulfonamides Local anesthetics Salicylates
Mold spores Animal hair and dander Latex
Table 15-1 Kuby IMMUNOLOGY, Sixth Edition © 2007 W. H. Freeman and Company
IgE-mediated diseases
in humans
• Systemic (anaphylactic shock)
• Asthma
– Classification by immunopathological
management strategies
• Hay fever (allergic rhinitis)
• Allergic conjunctivitis
• Skin reactions
• Food allergies
Diseases in Humans (I)
• Systemic anaphylaxis -
potentially fatal - due to food
pressure.
Diseases in Humans (II)
Bronchial asthma
• Chronic inflammation
– Intermittent & reversible airway
obstruction – Chronic bronchial
TNF-a
V 1 Mast cell IL-4 I
APC IL-5
Histamine
ECE
NCF LTCA
PGD2
LTC4 Vasodilation Recruitment of inflammatory cells Mucus
Inflammatory secretion
Broncho
cells (eosinophils; constriction
neutrophils)
Mucous glands
Epithelial
injury
So
response
Early response
Eosinophils
Blood vessel
Vinn
20
Thickened basement membrane
Curschmann's spirals
Mediators and
treatment of asthma
19-10
Anti-IL-13 - reduce mucus overproduction and eosinophilia
Anti-chemokine receptors: CCR3, CCR4, CCR8 on Th2
cells.
Anti-RANTES or -eotaxin abs to prevent recruitment of
eosinophils
Targeting Syk
Diseases in Humans (III)
• Upper respiratory tract – Allergic rhinitis (hay
Treatment - antihistamines
• Gastrointestinal tract – Result from release of
with steroids.
Copyright Slice of Life & Suzanne S. Stensaas - obtained from PEIR, Dept. of
Pathology, UAB
Urticaria
Copyright Slice of Life & Suzanne S. Stensaas - obtained from PEIR, Dept. of
Pathology, UAB
Atopic Eczema
Radioallergosorbent Test
(RAST)
1st study of allergen-specific
immunotherapy:
Noon, L. Prophylactic inoculation
against hay fever Lancet I,
1572-1573 (1911)
Desensitization/Allergen-Specific
Immunotherapy
Subcutaneous or sublingual administration
Peanut Flour May Ease Peanut Allergy
from WebMD — a health information Web site for patients
Non-autoimmune type
II reactions
• Transfusion reactions (ABO
incompatibility
• Hemolytic disease of the
newborn (erythroblastosis
fetalis)
PREVENTION (WITH RHOGAM)
DEVELOPMENT OF ERYTHROBLASTOSIS FETALIS
(WITHOUT RHOGAM)
Placenta
Mother
Plasma Maternal
cells circulation
cells
www
.
B cell
Anti-Rh IgM
Rhogam
RBCs with Rh antigen
1st Pregnancy
Delivery
Rh-specific
B cell
Memory cell
Plasma
Memory cell
hlag dicells
2nd Pregnancy
IgG anti-Rh Ab crosses placenta and attacks fetal RBCs causing
erythroblastosis fetalis
Figure 15-14 Kuby IMMUNOLOGY, Sixth Edition © 2007 W.H.Freeman and Company
Abbas and Lichtman, Cellular and Molecular Immunology (5th edition). Elsevier 2003.
malaria, trypanosomiasis
Kumar et al. Robbins and Cotran Pathologic Basis of Disease. Elsevier 2005.
Kumar et al. Robbins and Cotran Pathologic Basis of Disease. Elsevier 2005.
Balkwill & Rolph, Germ Zappers, Cold Spring Harbor Laboratory Press, 2001
Balkwill & Rolph, Germ Zappers, Cold Spring Harbor Laboratory Press, 2001
(Th1)
IFN-γ, LT, IL-2, IL-3, GM-CSF, MIF IL-8, MCP-1
Kumar et al. Robbins and Cotran Pathologic Basis of Disease. Elsevier 2005
Type IV hypersensitivity
(DTH)
TABLE 15-6
Intracellular pathogens and contact antigens that
induce delayed-type (type IV) hypersensitivity
Intracellular viruses
Herpes simplex
Table 15-6 Kuby IMMUNOLOGY, Sixth Edition © 2007 W.H. Freeman and Company
Intracellular bacteria
APC
CD4+TH
Antigen-presenting
cells: Macrophages Langerhans cells
DTH-mediating cells:
TH1 cells generally CD8 cells occasionally
Figure 15-17a Kuby IMMUNOLOGY, Sixth Edition © 2007 W. H. Freeman and Company
Effector phase
Class II MHC
TNF receptor
Secreted IFN
V
Membrane
TNF-B Sensitized
Resting TH1
macrophage
Activated macrophage
TH1 secretions:
Cytokines: IFN-Y, TNF-B,
IL-2,
IL-3, GM-CSF, MIF Chemokines: IL-8/CXCL8,
MCP-1/CCL2
Effects of macrophage activation:
1 Class II MHC molecules 1 TNF receptors 1 Oxygen
radicals 1 Nitric oxide
Figure 15-17b Kuby IMMUNOLOGY, Sixth Edition © 2007 W. H. Freeman and Company
Pentadecacatechol
LOH
(CH2),CH=CHCH,CH=CH(CH2)2CH3
Pentadecacatechol
Skin
Skini i
de o Self protein
Sensitized TH1
IFNY
SO
w
I
MCP
MCP-1 Loco
Langerhans cell (APC)
Lyticesc
enzymes
Tissue macrophage
Monocyte
Tissue macrophage
Figure 15-20 Kuby IMMUNOLOGY, Sixth Edition © 2007 W. H. Freeman and Company
Tuberculosis
Roitt 24.23